PL375233A1 - Leki inhalacyjne zawierające nowy lek antycholinoesterazowy w połączeniu z kortykosteroidami i lekami betamimetycznymi - Google Patents
Leki inhalacyjne zawierające nowy lek antycholinoesterazowy w połączeniu z kortykosteroidami i lekami betamimetycznymiInfo
- Publication number
- PL375233A1 PL375233A1 PL03375233A PL37523303A PL375233A1 PL 375233 A1 PL375233 A1 PL 375233A1 PL 03375233 A PL03375233 A PL 03375233A PL 37523303 A PL37523303 A PL 37523303A PL 375233 A1 PL375233 A1 PL 375233A1
- Authority
- PL
- Poland
- Prior art keywords
- corticosteroids
- conjunction
- anticholinergic
- beta
- medicaments containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10237739A DE10237739A1 (de) | 2002-08-17 | 2002-08-17 | Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL375233A1 true PL375233A1 (pl) | 2005-11-28 |
| PL212070B1 PL212070B1 (pl) | 2012-08-31 |
Family
ID=30775387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL375233A PL212070B1 (pl) | 2002-08-17 | 2003-07-25 | Kompozycje farmaceutyczne do inhalacji zawierające lek antycholinergiczny i kortykosteroid i ich zastosowanie |
Country Status (21)
| Country | Link |
|---|---|
| EP (2) | EP1785136A3 (pl) |
| JP (1) | JP2006501253A (pl) |
| KR (1) | KR101083977B1 (pl) |
| CN (1) | CN1688308A (pl) |
| AT (1) | ATE366574T1 (pl) |
| AU (1) | AU2003255289B2 (pl) |
| BR (1) | BR0313526A (pl) |
| CA (1) | CA2495454C (pl) |
| CO (1) | CO5540380A2 (pl) |
| CY (1) | CY1107742T1 (pl) |
| DE (2) | DE10237739A1 (pl) |
| DK (1) | DK1530471T3 (pl) |
| ES (1) | ES2290549T3 (pl) |
| IL (1) | IL166891A (pl) |
| MX (1) | MXPA05001823A (pl) |
| NZ (1) | NZ538834A (pl) |
| PL (1) | PL212070B1 (pl) |
| PT (1) | PT1530471E (pl) |
| RU (1) | RU2332217C2 (pl) |
| WO (1) | WO2004022058A1 (pl) |
| ZA (1) | ZA200500019B (pl) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1775305T1 (sl) | 2000-08-05 | 2015-01-30 | Glaxo Group Limited | S-fluorometil ester 6alfa,9alfa-difluoro-17alfa-((2-furanilkarboksil)oksi)- 11beta-hidroksi-16alfa-metil-3-okso-androst-1,4-dien-17-karbotiojske kisline kot protivnetno sredstvo |
| KR100831534B1 (ko) | 2001-04-30 | 2008-05-22 | 글락소 그룹 리미티드 | 17.알파 위치에 시클릭 에스테르기를 지닌 항염증성의안드로스탄의 17.베타.-카르보티오에이트 에스테르 유도체 |
| US7056916B2 (en) | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
| DE102004024453A1 (de) * | 2004-05-14 | 2006-01-05 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue langwirksame Bronchodilatoren zur Behandlung von Atemwegserkrankungen |
| US7745621B2 (en) | 2004-05-14 | 2010-06-29 | Boehringer Ingelheim International Gmbh | Long acting bronchodilators for the treatment of respiratory diseases |
| US7220742B2 (en) | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
| US20060034776A1 (en) * | 2004-08-10 | 2006-02-16 | Boehringer Ingelheim International Gmbh | Inhalable medicaments containing a new anticholinergic, corticosteroids, and betamimetics |
| DE102004056578A1 (de) * | 2004-11-23 | 2006-05-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Formoterol und ein Steroid |
| DE102004056579A1 (de) * | 2004-11-23 | 2006-05-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid |
| EP1850831B1 (en) | 2005-02-25 | 2015-12-02 | CHIESI FARMACEUTICI S.p.A. | Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent |
| EP2484382A1 (en) * | 2005-03-30 | 2012-08-08 | Schering Corporation | Medicament comprising a phosphodiesterase IV inhibitor in an inhalable form |
| RU2369411C2 (ru) * | 2005-04-21 | 2009-10-10 | Бёрингер Ингельхайм Интернациональ Гмбх | Порошковый ингалятор |
| JP2008538758A (ja) * | 2005-04-23 | 2008-11-06 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 抗コリン作用薬に加えてベータ受容体刺激薬及びステロイドを含有する吸入用の医薬組成物 |
| RU2431501C2 (ru) * | 2005-07-14 | 2011-10-20 | Липотера, Инк. | Липолитические составы с пролонгированным высвобождением для локального лечения отложения жировых тканей |
| BRPI0614410A2 (pt) | 2005-08-15 | 2011-03-29 | Boehringer Ingelheim Int | processo para preparação de betamiméticos |
| KR20100072295A (ko) * | 2007-10-25 | 2010-06-30 | 머크 프로스트 캐나다 리미티드 | 병용 요법 |
| US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
| PL3111927T3 (pl) | 2009-05-29 | 2020-06-29 | Pearl Therapeutics, Inc. | Kompozycje do wziewnego podawania środków aktywnych oraz związane z nimi sposoby i systemy |
| RU2479304C1 (ru) * | 2012-05-29 | 2013-04-20 | Шолекс Девелопмент Гмбх, | Стабильный раствор фенотерола гидробромида |
| RU2504382C1 (ru) * | 2012-06-13 | 2014-01-20 | Шолекс Девелопмент Гмбх | Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения |
| LT3473255T (lt) | 2012-12-21 | 2022-03-10 | Boehringer Ingelheim Vetmedica Gmbh | Farmacinė vaisto forma, apimanti ciklezonidą |
| BR112015010842B1 (pt) | 2012-12-21 | 2021-03-30 | Boehringer Ingelheim Vetmedica Gmbh | Uso da ciclesonida para o tratamento de doença das vias respiratórias em cavalos |
| SG11201507286QA (en) | 2013-03-15 | 2015-10-29 | Pearl Therapeutics Inc | Methods and systems for conditioning of particulate crystalline materials |
| WO2015065223A1 (ru) * | 2013-10-28 | 2015-05-07 | Шолекс Девелопмент Гмбх | Стабильный раствор фенотерола гидробромида |
| WO2015065220A1 (ru) * | 2013-10-28 | 2015-05-07 | Шолекс Девелопмент Гмбх | Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения |
| ES2759247T3 (es) * | 2014-06-18 | 2020-05-08 | Boehringer Ingelheim Vetmedica Gmbh | Antagonistas muscarínicos y combinaciones de estos para el tratamiento de enfermedades de las vías respiratorias en caballos |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003935D0 (en) * | 2000-02-08 | 2000-04-12 | King S College London | Formulation for dry powder inhaler |
| AU2000250701B2 (en) * | 2000-05-22 | 2004-07-01 | Chiesi Farmaceutici S.P.A. | Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
| DE10050994A1 (de) * | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung |
| DE10130371A1 (de) * | 2001-06-23 | 2003-01-02 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika |
-
2002
- 2002-08-17 DE DE10237739A patent/DE10237739A1/de not_active Withdrawn
-
2003
- 2003-07-25 BR BR0313526-8A patent/BR0313526A/pt not_active IP Right Cessation
- 2003-07-25 KR KR1020057002691A patent/KR101083977B1/ko not_active Expired - Fee Related
- 2003-07-25 PL PL375233A patent/PL212070B1/pl not_active IP Right Cessation
- 2003-07-25 DK DK03793643T patent/DK1530471T3/da active
- 2003-07-25 CA CA2495454A patent/CA2495454C/en not_active Expired - Fee Related
- 2003-07-25 JP JP2004533275A patent/JP2006501253A/ja active Pending
- 2003-07-25 WO PCT/EP2003/008222 patent/WO2004022058A1/de not_active Ceased
- 2003-07-25 EP EP07103257A patent/EP1785136A3/de not_active Withdrawn
- 2003-07-25 AT AT03793643T patent/ATE366574T1/de active
- 2003-07-25 AU AU2003255289A patent/AU2003255289B2/en not_active Ceased
- 2003-07-25 DE DE50307659T patent/DE50307659D1/de not_active Expired - Lifetime
- 2003-07-25 EP EP03793643A patent/EP1530471B1/de not_active Expired - Lifetime
- 2003-07-25 CN CNA038237989A patent/CN1688308A/zh active Pending
- 2003-07-25 NZ NZ538834A patent/NZ538834A/en not_active IP Right Cessation
- 2003-07-25 RU RU2005107475/15A patent/RU2332217C2/ru not_active IP Right Cessation
- 2003-07-25 MX MXPA05001823A patent/MXPA05001823A/es active IP Right Grant
- 2003-07-25 ES ES03793643T patent/ES2290549T3/es not_active Expired - Lifetime
- 2003-07-25 PT PT03793643T patent/PT1530471E/pt unknown
-
2005
- 2005-01-03 ZA ZA200500019A patent/ZA200500019B/en unknown
- 2005-02-15 IL IL166891A patent/IL166891A/en not_active IP Right Cessation
- 2005-03-15 CO CO05024193A patent/CO5540380A2/es not_active Application Discontinuation
-
2007
- 2007-09-19 CY CY20071101217T patent/CY1107742T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2332217C2 (ru) | 2008-08-27 |
| DE10237739A1 (de) | 2004-02-26 |
| EP1530471B1 (de) | 2007-07-11 |
| DE50307659D1 (de) | 2007-08-23 |
| CA2495454A1 (en) | 2004-03-18 |
| EP1785136A3 (de) | 2009-04-22 |
| ZA200500019B (en) | 2006-07-26 |
| RU2005107475A (ru) | 2006-04-10 |
| CA2495454C (en) | 2011-09-06 |
| JP2006501253A (ja) | 2006-01-12 |
| MXPA05001823A (es) | 2005-04-19 |
| KR20050051644A (ko) | 2005-06-01 |
| EP1530471A1 (de) | 2005-05-18 |
| CN1688308A (zh) | 2005-10-26 |
| KR101083977B1 (ko) | 2011-11-22 |
| DK1530471T3 (da) | 2007-10-22 |
| AU2003255289A1 (en) | 2004-03-29 |
| PL212070B1 (pl) | 2012-08-31 |
| AU2003255289B2 (en) | 2009-08-20 |
| PT1530471E (pt) | 2007-07-26 |
| WO2004022058A1 (de) | 2004-03-18 |
| CO5540380A2 (es) | 2005-07-29 |
| EP1785136A2 (de) | 2007-05-16 |
| CY1107742T1 (el) | 2013-04-18 |
| IL166891A (en) | 2010-04-15 |
| BR0313526A (pt) | 2005-06-28 |
| ES2290549T3 (es) | 2008-02-16 |
| ATE366574T1 (de) | 2007-08-15 |
| NZ538834A (en) | 2007-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL375233A1 (pl) | Leki inhalacyjne zawierające nowy lek antycholinoesterazowy w połączeniu z kortykosteroidami i lekami betamimetycznymi | |
| JP2003504368A5 (pl) | ||
| CY1108776T1 (el) | Σκευασμα αερολυματος για εισπνοη που περιεχει αντιχολινεργικο | |
| RU2005121162A (ru) | Производные хинуклидина, фармацевтическая композиция и способ лечения респираторных, урологических или желудочно-кишечных заболеваний | |
| AU775588B2 (en) | Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics | |
| TW449597B (en) | Pharmaceutical compositions with anticholinergic activity | |
| UY28527A1 (es) | Formularios de aerosol destinadaa la inhalación, que contiene un agente anticolinergico | |
| NZ524396A (en) | Fentanyl composition for nasal administration comprising water as a solvent | |
| RU2013155903A (ru) | Композиции, способы и устройства для респираторной доставки двух или более активных средств | |
| ES2295929T3 (es) | Tratamiento de suspension de la dependencia. | |
| AR039404A1 (es) | Combinaciones de medicamentos que contienen compuestos heterociclicos y un agente anticolinergico. aerosol para su inhalacion | |
| JP2005508963A5 (pl) | ||
| ZA200409676B (en) | Novel drug compositions based on novel anticholinergics and inhibitors of EGFR-kinase | |
| AR039275A1 (es) | Medicamento que contiene esteroides y un nuevo anticolinergico | |
| IL43820A (en) | Pharmacological preparations for the treatment of deformed disabled, containing symptomatic aminophytic bronchodilators | |
| PT1526848E (pt) | Antagonistas dos receptores de opióides em sistemas transdérmicos contendo buprenorfina | |
| AR059126A1 (es) | Uso de sales de tiotropio en el tratamiento del asma persistente moderada | |
| Vincken | Clinical efficacy and safety of the combination of ipratropium bromide and fenoterol inhaled via the Respimat© Soft Mist™ inhaler for relief of airflow obstruction | |
| Slattery et al. | Newer methods of delivery of opiates for relief of pain | |
| AR039634A1 (es) | Medicamento que contiene betamimeticos y un anticolinergico | |
| AU2003208703A1 (en) | Difurylglycolic acid tropenol esters used as anticholinesterase drugs | |
| Chen et al. | Bronchoconstriction following exposure to cocaine test atmospheres | |
| Baker et al. | Normal pharmacokinetics of doxapramin in a patient with renal failure and hypothyroidism | |
| Østerlind et al. | Vindesine in the Treatment of Lung Cancer– | |
| CA3157364A1 (en) | Prophylaxis and reversal of stimulant and opioid/opiate overdose and/or toxic exposure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Decisions on the lapse of the protection rights |
Effective date: 20130725 |